03.30.2019 Issue 165

Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Jobs Round-up
Job of the Week Latest Jobs from the Jobs Portal

 Health Economics and Real-World
Evidence (HE-RWE) Scientist

The successful candidate will join our growing team in Ireland and will be involved in the daily management of PHMR research projects across a wide range of methodological and therapeutic areas, including oncology, infectious disease, cardiovascular disease, diagnostics, and neurological disorders.

Senior Medical Writer

Senior Research Analyst (HEOR)

Medical Statistician

Senior Health Economics & Real-World Evidence (HE-RWE) Scientist

Senior Health Economics/Outcomes Researcher

Senior Health Economist (HTA and Market Access)

Head of Economic Modelling

Director, Real World Value and Evidence, Oncology

Highlights from NPC, Discern Health Webinar

Questions Loom on Post-Gottlieb FDA

Article: Germany as Model for Single-Payer System

Analysis: ICER Framework in Medicaid Could Threaten 820K Prescriptions

Industry Spotlight

Conferences Webinars
META Tool Facilitation Training Day
    April 2, London, U.K.

The HealthTech Summit USA 2019
    April 4, Philadelphia, Pennsylvania

Decision Analytic Modelling for Economic Evaluation
    April 8-9, York, England

Copay Accumulator Programs Summit West
    April 9, San Francisco, California

The Use of MCDA for HTA Agencies – Options, Limitations, and the Way Forward
    April 3

MCDA - How to Guide Through the Application of Different Methods for Assessment and Prioritization of Rare Disease Health Technologies
    April 4

Big Data, RWD and RWE: What’s the Difference and How is it Changing the Research Landscape?
    April 15

Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Review of Influence: The Institute for Clinical and Economic Review

Innovative Drugs: Mapping the Pricing and Reimbursement Landscape

Orphan Drugs: European Payer Perspectives

Do Payers Really Want Pay-for-Performance?

Payer Engagement: Benchmarking Team Structure and Activity

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

2018 Specialty Drug Trends

The Global Use of Medicine in 2019 and Outlook to 2023

Breaking Through the Hype of Real-World Evidence

Time to Market: Accelerating Market Access

Orphan Drugs in the United States

Charting Real World Data and Evidence – Activity and Capabilities (2018)

Special Thanks to Our Partners:
              Evidera    HealthCore    University of FL
      Xcenda    OM1    Parexel    Jefferson    Dymaxium    
      Precision Xtract    Pharmerit    eMax Health    Sciformix
       Evidence Partners     ICON